Jyoti Kumari

Jyoti Kumari

Auto-generated profile, based on publicly available information

Jyoti Kumari

Department of Dentistry-Orthodontics and Craniofacial Biology, Research Institute for Medical Innovation, Radboud university medical center, Philips van Leydenlaan 25, Nijmegen 6525 EX, the Netherlands; Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, Nijmegen 6525 AJ, the Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in Advanced Materials
Verified
Journal Article
Open access
WCWen Chen
Wen Chen
JKJyoti Kumari
Jyoti Kumari
HYHongbo Yuan
Hongbo Yuan
FYFan Yang
Fan Yang
PKPaul Kouwer
Paul Kouwer
The materials properties of biological tissues are unique. Nature is able to spatially and temporally manipulate (mechanical) properties while maintaining responsiveness toward a variety of cues; all without majorly changing the material's composition. Artificial mimics, synthetic or biomaterial‐based are far less advanced and poorly reproduce the natural cell microenvironment. A viable strategy to generate materials with advanced properties combines different materials into nanocomposites. This work describes nanocomposites of a synthetic fibrous hydrogel, based on polyisocyanide (PIC), that is noncovalently linked to a responsive cross‐linker. The introduction of the cross‐linker transforms the PIC gel from a static fibrous extracellular matrix mimic to a highly dynamic material that maintains biocompatibility, as demonstrated by in situ modification of the (non)linear mechanical properties and efficient self‐healing properties. Key in the material design is cross‐linking at the fibrillar level using nanoparticles, which, simultaneously may be used to introduce more advanced properties.

1 October 2014 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
DKDeepak Kumar
Deepak Kumar
JKJyoti Kumari
Jyoti Kumari
SPSunandan Pakrashi
Sunandan Pakrashi
SDSwayamprava Dalai
Swayamprava Dalai
ARAshok M. Raichur
Ashok M. Raichur
AMAmitava Mukherjee
Amitava Mukherjee

9 December 2022 in Advanced Therapeutics
Verified
Journal Article
Open access
JKJyoti Kumari
Jyoti Kumari
TWTirza Wubs
Tirza Wubs
ACArjan P.M. van Caam
Arjan P.M. van Caam
DDDaphne Naomie Dorst
Daphne Naomie Dorst
FWFrank Wagener
Frank Wagener
PKPaul Kouwer
Paul Kouwer
Systemic sclerosis (SSc) is a rare autoimmune disease with limited treatment options that is characterized by fibrosis in various organs. To screen the effectiveness of new therapies, there is an urgent need for reliable in vitro models. Key is that diseased cells' characteristics are maintained, which is challenging in currently used setups. In this study, an in vitro 3D culture system is described using the biocompatible polyisocyanide (PIC‐RGD) hydrogel and SSc patient‐derived fibroblasts from affected (lesional cells) and from healthy‐skin (healthy cells). In contrast to the standard collagen‐coated 2D cultures, the cells in the 3D PIC‐RGD gels maintain the native phenotype and functionality of the primary cells. The functionality of the model is studied in the presence of the fibrosis stimulator transforming growth factor β1 (TGFβ1) and the suppressor tumor necrosis factor (TNFα). In this study, it is observed that lesional cells have a stronger fibrotic character with increased contraction, proliferation, and expression of collagen, and myofibroblast markers α‐smooth muscle actin and fibroblast activation protein. The high tunability of the hydrogel, which can maintain the native functionality of fibroblasts in in vitro cultures, delivers a crucial step in developing these materials into an effective tool for personalized medicine approaches of SSc patients.

6 January 2025 in Archives of Oral Biology
Verified
Journal Article
Open access
RVRaquel Veloso Varanda
Raquel Veloso Varanda
JKJyoti Kumari
Jyoti Kumari
RRRené E.M. van Rheden
René E.M. van Rheden
VCVincent M.J.I. Cuijpers
Vincent M.J.I. Cuijpers
MBMarjon Bloemen
Marjon Bloemen
CSChristaan Maarten Suttorp
Christaan Maarten Suttorp
To investigate in vivo whether myofibroblasts formed in the PDL after exposure to short-term high experimental orthodontic forces in rats survive. To study in vitro whether human PDL fibroblasts can differentiate into myofibroblasts and survive when chemical or mechanical stimuli are removed. Nine 6-week-old male Wistar rats were used in this experiment. Rat molars were exposed to high but rapidly decreasing experimental orthodontic forces by applying a rubber band and analyzed for the presence of myofibroblasts using ASMA staining. In vitro, human periodontal ligament (PDL) fibroblasts were exposed to transforming growth factor β1 (TGFβ1) and/or mechanical stress and monitored for myofibroblast formation and survival after these stimuli were abrogated. In vivo exposure to orthodontic forces strongly induced myofibroblast formation in the stretched regions of the PDL. Furthermore, many PDL myofibroblasts remained present 6 days after exposure to these short-term high orthodontic forces. Human PDL fibroblasts were shown to differentiate into myofibroblasts after 2 days of TGFβ1 exposure and survive for at least 2 more days after removing chemical stimuli (TGFβ1) or mechanical strain. Under in vitro conditions, both TGFβ1 and mechanical strain for 3 days promoted (myo)fibroblast formation, and these cells persisted for 3 more days after the removal of both stimuli. PDL myofibroblasts survive after the removal of mechanical strain in vivo and in vitro. This supports the hypothesis that myofibroblasts, which form in response to mechanical strain and chemical cues in the periodontal ligament (PDL), play a role in relapse following orthodontic tooth movement.

18 December 2024 in Rheumatology Advances in Practice
Verified
Journal Article
Open access
IKIlmar Kruis
Ilmar Kruis
JKJyoti Kumari
Jyoti Kumari
AHAnnemarie van der Heijden
Annemarie van der Heijden
AWAmrah Weijn
Amrah Weijn
WEWilma Vree Egberts
Wilma Vree Egberts
GPGer Pruijn
Ger Pruijn
Objectives: ACPAs play an important role in the classification of RA and can be detected by serological tests. Several ACPA detection assays are available for clinical use, which are all based on ELISA(-like) tests with citrullinated peptides (CCP2) or alternative citrullinated proteins/peptides. We aimed to facilitate ACPA detection in low-volume laboratories and resource-poor environments by developing a rapid and easy-to-perform test. Methods: We designed and generated an agglutination mediator by protein engineering. A single-chain antibody fragment that binds to glycophorin A, one of the major surface proteins of erythrocytes, was conjugated to a CCP2-like peptide. This agglutination mediator was used to assess ACPA in RA and PsA patients and in healthy individuals. Results: The agglutination mediator bound to erythrocytes was reactive with ACPA and induced haemagglutination in an ACPA-dependent fashion, which can be detected by the naked eye. The applicability was assessed by the analysis of fresh blood samples from 204 RA patients, 77 PsA patients and 100 healthy individuals. Agglutination was observed in up to 61% of the RA samples, which correlated well with the results obtained with a standardized anti-CCP2 ELISA (63–67%). Depending on the minimal agglutination score, agglutination was observed in only 3–21% of the PsA samples and in 1% of the healthy controls. Conclusion: We conclude that the agglutination mediator allows rapid and efficient detection of ACPA by haemagglutination in human blood samples and offers a low-threshold method for ACPA detection.

23 October 2026 in Science Advances
Verified
Journal Article
Closed access
WCWen Chen
Wen Chen
ZGZhengdong Gao
Zhengdong Gao
HWHongjuan Weng
Hongjuan Weng
HYHongbo Yuan
Hongbo Yuan
RARoy van Alst
Roy van Alst
PKPaul Kouwer
Paul Kouwer
Omnipresent in biology, fibrous networks like collagen possess unique properties: dynamic network via crosslinking and degradation. This intrinsic adaptivity plays a critical role in regulating cell behavior via cell-matrix interactions. Built from biological building blocks, however, these networks are challenging to manipulate or even control. Here, we introduce dynamic network regulation via photochemical control in a synthetic and fibrous highly biomimetic hydrogel. As a proof-of-concept, we demonstrate that the dynamic control over the mechanical properties of this adaptive in vitro model can be used to modulate cell spreading and mechanotransduction in three-dimensional (3D) mesenchymal stromal cell cultures. Our approach not only opens the door to on-demand mechanically adaptive gels with unprecedented control, but simultaneously offers easy processibility and cell extraction of the used synthetic gel.